These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 2858584)

  • 21. Stereoselectivity of S- and R-sulpiride for pre- and postsynaptic dopamine receptors in the canine kidney.
    Bass AS; Robie NW
    J Pharmacol Exp Ther; 1984 Apr; 229(1):67-71. PubMed ID: 6707948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
    Ensinger H; Majewski H; Hedler L; Starke K
    J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional role of alpha-calcitonin gene-related peptide in the regulation of the cardiovascular system.
    Shen YT; Pittman TJ; Buie PS; Bolduc DL; Kane SA; Koblan KS; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 2001 Aug; 298(2):551-8. PubMed ID: 11454916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA; Wardell JR; Sarau HM; Ridley PT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of the novel inotropic agent, ASL-7022, with alpha and beta adrenoceptors in the cardiovascular system of the pithed rat: comparison with dobutamine and dopamine.
    Ruffolo RR; Morgan EL
    J Pharmacol Exp Ther; 1984 May; 229(2):364-71. PubMed ID: 6325661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine-induced coronary effects in the dog heart attributed to beta- and alpha-adrenergic mechanisms.
    Rabloczky G; Kékesi V; Mader MR; Juhász-Nagy A
    Arch Int Pharmacodyn Ther; 1988; 293():109-26. PubMed ID: 2844127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.
    Merlo L; Ghirardi P; Brusoni B; Mussini E; Marchetti G
    Arzneimittelforschung; 1986 Feb; 36(2A):304-11. PubMed ID: 3707641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of some renal and cardiovascular effects of a prostaglandin analog, SKF 82526 and ibopamine in anesthetized dogs.
    Seymour AA; Blaine EH
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):304-15. PubMed ID: 6148046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of epinine on systemic hemodynamics and regional blood flow in conscious pigs.
    van Woerkens LJ; Man in 't Veld AJ; van der Giessen WJ; van Meegen J; Boomsma F; Verdouw PD
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):580-6. PubMed ID: 1380601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary vascular activity of the novel inotropic pro-drug ibopamine and the de-esterified active form epinine.
    Ohlstein EH; Kopia GA; Ruffolo RR
    Arzneimittelforschung; 1988 Dec; 38(12):1790-2. PubMed ID: 3245851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
    Bass AS; Kohli JD; Lubbers N; Goldberg LI
    J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presynaptic dopamine receptor stimulation in the cardiovascular actions of lergotrile.
    Barrett RJ; Lokhandwala MF
    J Pharmacol Exp Ther; 1981 Jun; 217(3):660-5. PubMed ID: 6112262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog.
    Woodman OL; Vatner SF
    J Pharmacol Exp Ther; 1986 Apr; 237(1):86-91. PubMed ID: 2870177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
    Grega GJ; Barrett RJ; Adamski SW; Lokhandwala MF
    J Pharmacol Exp Ther; 1984 Jun; 229(3):756-62. PubMed ID: 6144791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the cardiovascular effects of co-derocrine (Hydergine).
    Clark BJ; Bucher T; Waite R
    J Pharmacol; 1985; 16 Suppl 3():101-11. PubMed ID: 2869189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.
    Lappe RW; Todt JA; Wendt RL
    J Pharmacol Exp Ther; 1986 Jan; 236(1):187-91. PubMed ID: 2867214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of plasma cholinesterase prevents the dopamine DA-1 receptor mediated renal vasodilation produced by ibopamine.
    Nichols AJ; Shebuski RJ; Ruffolo RR
    Eur J Pharmacol; 1987 Sep; 141(3):515-8. PubMed ID: 3666046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.